Collectively, these findings raise the possibility that the oncogenesis‐derived CRT may trigger the immune system to produce autoantibodies against CRT during the anti‐tumor response, which may contribute to the development of paraneoplastic myositis.31, 32. Here, CALR is linked to neoplasm.